The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa
Authors
O'Brien, Daniel PComte, Eric
Serafini, Micaela
Ehounou, Geneviève
Antierens, Annick
Vuagnat, Hubert
Christinet, Vanessa
Hamani, Mitima D
du Cros, Philipp
Affiliation
Manson Unit, Médecins Sans Frontières, London, UK; Department of Infectious Diseases, Geelong Hospital, Geelong, VIC, Australia; Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia. Electronic address: daniel.obrien@amsterdam.msf.org.Issue Date
2013-12-02
Metadata
Show full item recordJournal
The Lancet Infectious DiseasesAbstract
Despite great advances in the diagnosis and treatment of Buruli ulcer, it is one of the least studied major neglected tropical diseases. In Africa, major constraints in the management of Buruli ulcer relate to diagnosis and treatment, and accessibility, feasibility, and delivery of services. In this Personal View, we outline key areas for clinical, diagnostic, and operational research on this disease in Africa and propose a research agenda that aims to advance the management of Buruli ulcer in Africa. A model of care is needed to increase early case detection, to diagnose the disease accurately, to simplify and improve treatment, to reduce side-effects of treatment, to deal with populations with HIV and tuberculosis appropriately, to decentralise care, and to scale up coverage in populations at risk. This approach will require commitment and support to strategically implement research by national Buruli ulcer programmes and international technical and donor organisations, combined with adaptations in programme design and advocacy. A critical next step is to build consensus for a research agenda with WHO and relevant groups experienced in Buruli ulcer care or related diseases, and we call on on them to help to turn this agenda into reality.Publisher
ElsevierPubMed ID
24309480Language
enISSN
1474-4457ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(13)70201-9
Scopus Count
Collections
Related articles
- HIV infection and Buruli ulcer in Africa.
- Authors: Vincent QB, Ardant MF, Marsollier L, Chauty A, Alcaïs A, Franco-Beninese Buruli Research Group (listed in appendix).
- Issue date: 2014 Sep
- Health services for Buruli ulcer control: lessons from a field study in Ghana.
- Authors: Ackumey MM, Kwakye-Maclean C, Ampadu EO, de Savigny D, Weiss MG
- Issue date: 2011 Jun
- Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
- Authors: Walsh DS, Eyase F, Onyango D, Odindo A, Otieno W, Waitumbi JN, Bulimo WD, Schnabel DC, Meyers WM, Portaels F
- Issue date: 2009 Dec
- Senegal, a new potential endemic country for Buruli ulcer?
- Authors: Dupechez L, Carvalho P, Hebert V, Marsollier L, Eveillard M, Marion E, Kempf M
- Issue date: 2019 Dec
- On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.
- Authors: Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, Portaels F, Yeboah-Manu D, Pluschke G, Seemann T, Stinear TP
- Issue date: 2012 Jun 19